The Insulin Trap: How We Traded Biology for a Business Model

 

The Insulin Trap: How We Traded Biology for a Business Model

Before 1922, an Type 1 diabetes diagnosis was essentially a death sentence. Yet, doctors like Frederick Allen discovered a brutal, effective survival strategy: the "starvation diet." By stripping away carbohydrates and flooding the body with animal fats—butter, lard, and organ meats—they forced the human metabolism into a state of ketosis. It wasn't a cure, but it was a bridge. It stopped the blood sugar spikes, halted the muscle-wasting decay, and bought these patients precious years. It was a biological hack that recognized a simple truth: if you don’t put the fire in, you don’t need the extinguisher.

Then came the miracle of injectable insulin, and with it, the birth of a monstrously profitable business model. The medical establishment performed a bait-and-switch. They whispered to patients: "Why bother with the misery of a fat-heavy diet when you can just eat whatever you want and inject the solution?" It was a seductive, lethal lie. By prioritizing convenience over metabolic discipline, the industry ensured that patients would be tethered to a lifetime of dependency.

The "standard of care" shifted from managing the underlying metabolic state to simply managing the symptoms. The pharmaceutical machine realized that a patient who eats freely and injects insulin is a perpetual revenue stream; a patient who stabilizes their metabolism through fat-based dietary control is a threat to the bottom line. So, they sold a dream of normality, while the long-term reality became a slow progression of chronic complications. We traded the wisdom of evolutionary biology for the comfort of a syringe, and the business model has been thriving ever since. In this system, your "freedom" to eat anything is the very thing that keeps you paying for the tools to survive it.

Prescription for Disaster: Hong Kong’s Healthcare Cost-Cutting Gamble

 

Prescription for Disaster: Hong Kong’s Healthcare Cost-Cutting Gamble

Hong Kong’s latest public healthcare fee reform, implemented in January 2026, was sold as a way to ensure "sustainability." But three months in, the cracks are showing. According to lawmaker Dr. David Lam (林哲玄), over 26,000 prescriptions went uncollected in the first two months alone—roughly 3% of the total.

In the eyes of a biologist or a historian, this is a classic case of selective pressure gone wrong. When you increase the cost of survival (even by a seemingly small margin), the "human animal" starts making desperate, often irrational trade-offs. The government hiked drug fees—now charging per drug for every four-week block—to curb "wastage." But as Desmond Morris might observe, humans aren't particularly good at calculating long-term risk when immediate resources are scarce.

The "unintended consequences" are a dark comedy of errors:

• The Survival Gambit: Patients are now "self-prescribing" by skipping doses or refusing medications to save money, erroneously prioritizing herbal supplements or immediate household costs over chronic disease management.

• The Systemic Backfire: By scaring patients away from follow-ups and medications, the government isn't saving money; it’s just deferring a much larger bill. A patient who skips $20 blood pressure pills today becomes the $50,000 emergency stroke admission tomorrow.

• Information Asymmetry: While the government touts "safety nets" and fee waivers, the bureaucracy often feels like a labyrinth designed to keep people out rather than pull them in.

This isn't just a policy hiccup; it’s a failure to account for the "darker side" of human behavior—the tendency to retreat from preventive care when the gatekeepers start charging admission. The irony? A reform meant to "save" the system may eventually be the very thing that drowns it in avoidable complications.